Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies

被引:58
作者
Attarian, S
Azulay, JP
Boucraut, J
Escande, N
Pouget, J
机构
[1] Univ Hosp Timone, Dept Neurol & Neuromuscular Dis, F-13385 Marseille, France
[2] Univ Hosp La Timone, Dept Immunol, F-13385 Marseille, France
关键词
modified F ratio; terminal latency index; myelin associated glycoprotein; chronic inflammatory demyelinating polyneuropathy; Charcot-Marie-Tooth disease type 1A;
D O I
10.1016/S1388-2457(01)00469-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To evaluate indexes calculated from standard electrophysiological data in differentiating chronic demyelinating polyneuropathy (CDP). Methods: Nerve conduction study of upper limbs was investigated in 19 chronic inflammatory demyelinating polyneuropathy (CIDP) patients, 25 anti-myelin-associated glycoprotein/sulfated glucuronyl paragloboside antibodies (MAG/SGPG) CDP patients, 13 Charcot-Marie-Tooth disease type 1A (CMT1A) patients and 22 controls. Terminal latency index (TLI) was used to compare the wrist-to-thenar muscle segment with the elbow-to-wrist conduction velocity. Modified F ratio (MFR) was used to compare the spinal cord-to-elbow segment latency with that of the wrist-to-thenar muscle segment. Results: Compared with controls, TLI was decreased in 21 anti-MAG/SGPG CDP patients while MFR was either decreased or was normal. In 16 CIDP patients, MFR was increased while TLI was either normal or increased. In CMT1A both TLI and MFR were in normal ranges. The sensitivity of MFR as a supportive finding in CIDP was found to be 84% and its specificity 89%. The sensitivity of TLI as a mean of diagnosis of anti-MAG/SGPG CDP was found to be 93% and its specificity 90%. Conclusion: The results of TLI and MFR facilitates distinction between different types of CDP. In CIDP, MFR was significantly higher and TLI showed no change; in the anti-MAG/SGPG CDP, TLI and MFR were significantly lower; in CMT1A, TLI and MFR showed no change in comparison with the controls. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:457 / 463
页数:7
相关论文
共 30 条
[1]  
AZULAY JP, 1992, REV NEUROL, V148, P752
[2]   CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY - CLINICAL CHARACTERISTICS, COURSE, AND RECOMMENDATIONS FOR DIAGNOSTIC-CRITERIA [J].
BAROHN, RJ ;
KISSEL, JT ;
WARMOLTS, JR ;
MENDELL, JR .
ARCHIVES OF NEUROLOGY, 1989, 46 (08) :878-884
[3]   ANTI-MAG ANTIBODY-ASSOCIATED POLYNEUROPATHIES - IMPROVEMENT FOLLOWING IMMUNOTHERAPY WITH MONTHLY PLASMA-EXCHANGE AND IV-CYCLOPHOSPHAMIDE [J].
BLUME, G ;
PESTRONK, A ;
GOODNOUGH, LT .
NEUROLOGY, 1995, 45 (08) :1577-1580
[4]   CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY - COMPARISON OF PATIENTS WITH AND WITHOUT AN ASSOCIATED MONOCLONAL GAMMOPATHY [J].
BROMBERG, MB ;
FELDMAN, EL ;
ALBERS, JW .
NEUROLOGY, 1992, 42 (06) :1157-1163
[5]   COMPARISON OF ELECTRODIAGNOSTIC CRITERIA FOR PRIMARY DEMYELINATION IN CHRONIC POLYNEUROPATHY [J].
BROMBERG, MB .
MUSCLE & NERVE, 1991, 14 (10) :968-976
[6]  
Chassande B, 1998, MUSCLE NERVE, V21, P55, DOI 10.1002/(SICI)1097-4598(199801)21:1<55::AID-MUS8>3.0.CO
[7]  
2-F
[8]  
CORNBLATH DR, 1991, NEUROLOGY, V41, P617
[9]  
DYCK PJ, 1975, MAYO CLIN PROC, V50, P621
[10]  
DYCK PJ, 1993, PERIPHERAL NEUROPATH, P1498